Clinical Trial Update: C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer [NA]

View source ↗

Summary

A clinical trial investigating C11 AMT PET imaging in patients with metastatic invasive breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• C11 AMT (11C-alpha-methyl-L-tryptophan)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer | NA | Status: WITHDRAWN